Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
UBS GroupOther | Endra Life SciencesNDRA | Open-market buyAmendment | 24/08/27 | 24/09/05 | 0 sh | $0.00 | $0 | 0.0% |
UBS Group10% Owner | Endra Life SciencesNDRA | Open-market buy | 24/08/27 | 24/08/29 | 3,715 sh | $0.55 | $2,043.25 | +2.6% |
Endra Life SciencesNDRA | Open-market buy | 23/05/18 | 23/05/22 | 15,000 sh | $1.65 | $24,750 | +78.4% | |
Anthony DigiandomenicoDirector | Endra Life SciencesNDRA | Open-market buy | 23/05/02 | 23/05/03 | 83,333 sh | $1.20 | $99,999.6 | +436.3% |
